Literature DB >> 11272192

beta-cell turnover: its assessment and implications.

S Bonner-Weir1.   

Abstract

The pancreatic beta-cells are responsible for the maintenance of the body's glucose levels within a very narrow range; their population is dynamic and undergoes compensatory changes to maintain euglycemia. The structural parameters that allow mass changes (replication, neogenesis, cell volume changes, and cell death) can now be assessed and have proved to be powerful tools. Changes in one parameter can dramatically affect the beta-cell mass. Unfortunately, conclusions are often drawn on measurements that do not assess beta-cell mass but only relative volumes. Throughout the lifetime of a mammal, low levels of beta-cell replication and apoptosis are balanced and result in a slowly increasing mass. The balance allows gradual replacement of the beta-cell population; thus, beta-cells should be considered a slowly renewed tissue. Two major implications of beta-cell turnover are that 1) at any time, the beta-cells would be at different ages and 2) any limitation on replacement could have dire consequences for glucose homeostasis.

Entities:  

Mesh:

Year:  2001        PMID: 11272192     DOI: 10.2337/diabetes.50.2007.s20

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  67 in total

1.  Cardio-renal and metabolic adaptations during pregnancy in female rats born small: implications for maternal health and second generation fetal growth.

Authors:  Linda A Gallo; Melanie Tran; Karen M Moritz; Marc Q Mazzuca; Laura J Parry; Kerryn T Westcott; Andrew J Jefferies; Luise A Cullen-McEwen; Mary E Wlodek
Journal:  J Physiol       Date:  2011-12-05       Impact factor: 5.182

Review 2.  The isolated pancreatic islet as a micro-organ and its transplantation to cure diabetes: celebrating the legacy of Paul Lacy.

Authors:  Stanley Misler
Journal:  Islets       Date:  2010 Jul-Aug       Impact factor: 2.694

3.  Contribution of postnatally formed small beta cell aggregates to functional beta cell mass in adult rat pancreas.

Authors:  M Chintinne; G Stangé; B Denys; P In 't Veld; K Hellemans; M Pipeleers-Marichal; Z Ling; D Pipeleers
Journal:  Diabetologia       Date:  2010-07-20       Impact factor: 10.122

Review 4.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 5.  Development, growth and maintenance of β-cell mass: models are also part of the story.

Authors:  Anmar Khadra; Santiago Schnell
Journal:  Mol Aspects Med       Date:  2015-02-23

Review 6.  Advances in diabetes for the millennium: toward a cure for diabetes.

Authors:  Aaron I Vinik; David Taylor Fishwick; Gary Pittenger
Journal:  MedGenMed       Date:  2004-08-24

Review 7.  Potential role of oral thiazolidinedione therapy in preserving beta-cell function in type 2 diabetes mellitus.

Authors:  Helmut Walter; Georg Lübben
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 8.  Beta cell mass in diabetes: a realistic therapeutic target?

Authors:  J J Meier
Journal:  Diabetologia       Date:  2008-03-04       Impact factor: 10.122

Review 9.  Islet vasculature as a regulator of endocrine pancreas function.

Authors:  Nikiforos Ballian; F Charles Brunicardi
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

10.  Effects of immunosuppression on alpha and beta cell renewal in transplanted mouse islets.

Authors:  C Krautz; S Wolk; A Steffen; K-P Knoch; U Ceglarek; J Thiery; S Bornstein; H-D Saeger; M Solimena; S Kersting
Journal:  Diabetologia       Date:  2013-03-27       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.